| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/24/2009 | US7507397 Delivery of muscle relaxants through an inhalation route |
| 03/24/2009 | CA2487586C Feed supplemented with ketoprofen and its use in the simultaneous treatment of conditions causing fever, inflammation and/or pain in a herd of animals |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/24/2009 | CA2382404C Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 03/19/2009 | WO2009035949A2 Soluble epoxide hydrolase inhibitors |
| 03/19/2009 | WO2009035497A2 Disease related cysteine modifications and uses thereof |
| 03/19/2009 | WO2009035068A1 Novel 1,3,3-trimethyl-7-phenyl-3,4-dihydro-1h-quinoxalin- 2-one derivatives |
| 03/19/2009 | WO2009035067A1 Glucocorticoid receptor agonists consisting of 1,3,3-tri- methyl-7-phenyl-3,4-dihydro-1h-quinoxalin-2-one derivatives |
| 03/19/2009 | WO2009034475A2 Perharidines as cdk inhibitors |
| 03/19/2009 | WO2009034411A1 Perharidines as cdk inhibitors |
| 03/19/2009 | WO2009034165A1 Wolfberries and skin inflammation |
| 03/19/2009 | WO2009034162A1 Wolfberries and inflammation |
| 03/19/2009 | WO2009033808A2 Use of a peptide as a therapeutic agent |
| 03/19/2009 | WO2009033764A2 Use of a peptide as a therapeutic agent |
| 03/19/2009 | WO2009033737A2 Use of gluten exorphin c : as a therapeutic agent |
| 03/19/2009 | WO2009033282A1 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects |
| 03/19/2009 | WO2009015812A3 Prodrugs of 2-amino-6- ( { [2- (4-chlorphenyl) -1, 3-thiaz0l-4-yl] methyl}thio) -4- [4- ( 2 -hydroxyethoxy) phenyl] pyridin-3, 5-dicarbonitrile |
| 03/19/2009 | WO2009007827A3 Novel diclofenac esters and uses thereof |
| 03/19/2009 | WO2009007673A3 Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a ppar gamma agonist |
| 03/19/2009 | WO2009000296A3 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 03/19/2009 | WO2008152226A3 Homogeneous and stable composition rich in oleaginous substances based on a milk product, method for the preparation thereof and uses thereof |
| 03/19/2009 | WO2008143954A3 Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto |
| 03/19/2009 | WO2008131946A3 Substituted amide derivatives |
| 03/19/2009 | US20090076256 Degradation-resistant mononucleoside phosphate compounds |
| 03/19/2009 | US20090076147 Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| 03/19/2009 | US20090076146 Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome |
| 03/19/2009 | US20090076143 Compositions and methods for treating inflammation and inflammation-related disorders by plectranthus amboinicus extracts |
| 03/19/2009 | US20090076135 Deuterium-enriched hydromorphone |
| 03/19/2009 | US20090076122 PARP Modulators and Treatment of Cancer |
| 03/19/2009 | US20090076120 Crystal of Aminopyrrolidine Derivative and Production Method Thereof |
| 03/19/2009 | US20090076101 Thiophene and Thiazole Substituted Trifluoroethanone Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 03/19/2009 | US20090076003 Phthalazine Derivatives with Angiogenesis Inhibiting Activity |
| 03/19/2009 | US20090075986 Anti-inflammatory medicaments |
| 03/19/2009 | US20090075985 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 03/19/2009 | US20090075983 Novel Diazabicycloalkane Derivatives and Their Medical Use |
| 03/19/2009 | US20090075981 INHIBITORS OF p38 |
| 03/19/2009 | US20090075975 Arylsulfonamides and uses related thereto |
| 03/19/2009 | US20090075955 Therapeutic regimens for the treatment of immunoinflammatory disorders |
| 03/19/2009 | US20090075952 Nitroderviatives as drugs for diseases having an inflammatory basis |
| 03/19/2009 | US20090075946 Novel triterpenic acid derivative and preparation for external application for skin comprising the same |
| 03/19/2009 | US20090075909 Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds |
| 03/19/2009 | US20090075874 Methods for construction and screening of libraries of chemokine variants |
| 03/19/2009 | US20090075872 Methods and means |
| 03/19/2009 | US20090075864 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 03/19/2009 | US20090074890 Substituted Triazoles as Sodium Channel Blockers |
| 03/19/2009 | US20090074875 Nanoparticulate compositions having lysozyme as a surface stabilizer |
| 03/19/2009 | US20090074863 Dosage Forms Containing A PPI, NSAID And A Buffer |
| 03/19/2009 | US20090074859 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 03/19/2009 | US20090074847 Transport System In Biological Systems |
| 03/19/2009 | US20090074765 Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage |
| 03/19/2009 | US20090074745 Treatment and prevention of tissue damage |
| 03/19/2009 | US20090074722 Products and methods for treating PTP lar diseases |
| 03/19/2009 | US20090074661 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 03/19/2009 | DE102007044277A1 Substituierte Nicotinamid-Verbindungen und deren Verwendung in Arzneimitteln Substituted nicotinamide compounds and their use in medicaments |
| 03/19/2009 | CA2699233A1 Wolfberries and skin inflammation |
| 03/19/2009 | CA2699040A1 Perharidines |
| 03/19/2009 | CA2698990A1 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects |
| 03/19/2009 | CA2698860A1 Wolfberries and inflammation |
| 03/19/2009 | CA2698831A1 Use of a peptide as a therapeutic agent |
| 03/18/2009 | EP2036905A1 Pyridylisoxazole derivative |
| 03/18/2009 | EP2036902A2 Urea compounds active as vanilloid receptor antagonist for the treatment of pain |
| 03/18/2009 | EP2036895A1 Hsp90 inhibitor |
| 03/18/2009 | EP2036891A2 Isoquinoline inhibitors of P38 |
| 03/18/2009 | EP2036888A1 Naphthyl-substituted sulfonamides |
| 03/18/2009 | EP2036565A1 Preparation for external application to skin containing triterpenic acid |
| 03/18/2009 | EP2036560A1 (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione for the treatment of benign prostatic hypertrophy |
| 03/18/2009 | EP2036558A2 Orally administrable opioid formulations having extended duration of effect |
| 03/18/2009 | EP2035573A1 Methods for identifying modulators of eoxin formation |
| 03/18/2009 | EP2035429A1 FUSED [d]PYRIDAZIN-7-ONES |
| 03/18/2009 | EP2035369A1 Therapeutic compounds |
| 03/18/2009 | EP2034994A2 Nf-kappa b inhibitors and uses thereof |
| 03/18/2009 | EP2034829A1 Pharmaceutical composition comprising cyclobenzaprine and aceclofenac in association |
| 03/18/2009 | EP1888514B1 Salts of substituted allophanates and their use in drugs |
| 03/18/2009 | EP1517918B1 Peptides having affinity for a phospholipid and uses |
| 03/18/2009 | EP1513806B1 Sulphonic acid salts of mandelic acid derivatives |
| 03/18/2009 | EP1389096B1 Delivery of opioids through an inhalation route |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | EP0979090B1 Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine |
| 03/18/2009 | EP0963984B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics |
| 03/18/2009 | CN101389626A Fused ring heterocycle kinase modulators |
| 03/18/2009 | CN101389611A Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 03/18/2009 | CN101389610A Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors |
| 03/18/2009 | CN101389321A Use of resveratrol and derivatives thereof for promoting the wellness state in mammals |
| 03/18/2009 | CN101387646A Complement pathway inhibitors binding to c5 and c5a without preventing formation of c5b |
| 03/18/2009 | CN101386590A Pyrrolidone containing hydroxymethyl and carboxyl, preparation method and medicament composition and use thereof |
| 03/18/2009 | CN101385847A Preparation method of minor decoction of green dragon |
| 03/18/2009 | CN101385843A Nano medicine magnet therapy plaster for relieving the swelling and easing pain |
| 03/18/2009 | CN101385832A Ventilation meridian oral liquid |
| 03/18/2009 | CN101385798A Wind dispelling and pain relieving paste for treating hyperostegeny |
| 03/18/2009 | CN101385784A Traditional Chinese medicine composition for preventing and treating rheumatic disease |
| 03/18/2009 | CN101385777A Medicine composition and its preparation and application |
| 03/18/2009 | CN101385776A Anti influenza use of main chemical component and active component in scabriculous herbamoslae |
| 03/18/2009 | CN101385764A Use of snow ganoderma lucidum total saponin in preparing analgesic medicine |
| 03/18/2009 | CN101385750A Preparation method of effective ingredient of isatis root |
| 03/18/2009 | CN101385743A Medicine for treating and preventing arthrosis and preparation method thereof |
| 03/18/2009 | CN101385724A Arginine Ibuprofen cream and preparation method thereof |
| 03/18/2009 | CN101385723A Association between an anti-atherothrombotic and an angiotensin conversion enzyme inhibitor |
| 03/18/2009 | CN101385704A Compound sulfamonomethoxine sodium injection and preparation method thereof |
| 03/18/2009 | CN101385600A Chinese herbal medicine health-care silk quilt |
| 03/18/2009 | CN101385539A Wean diet therapy method for eliminating the phlegm, cleaning the heat and nourishing the liver |